• Home
  • Centrient Pharmaceuticals

Centrient Pharmaceuticals

About Centrient Pharmaceuticals

Centrient Pharmaceuticals is the global business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals. We produce and sell intermediates and active pharmaceutical ingredients (APIs), as well as our own tablets, capsules and other finished dosage forms (FDFs).
First established in 1869, our story has since been one of constant evolution and innovation. Today, we are a company 2,200-people strong with operations on four continents.

More than this, we are a pharmaceutical company with a clear Purpose: to improve lives through ...

Read more Show less
Certifications
  • FDA
    FDA
  • GMP
    GMP
  • ISO
    ISO
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • NL
  • 2015
    On CPHI since
  • 3
    Certificates
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator
Primary activities
Finished Formulation products Distributor/Buyer
Generic APIs producer
View company profile
Contact info
  • +31152793278
  • Sir Winston Churchilllaan 299, 2288 DC, Rijswijk, Netherlands
Show contact info Hide contact info
Meet us at

CPHI Frankfurt 2025

Messe, Frankfurt
28 Oct 2025 - 30 Oct 2025
View Exhibitor Profile

Products from Centrient Pharmaceuticals (95)

  • API Product Portfolio

    Product API Product Portfolio

    Penicillin G Penicillin G potassium Penicillin G procaine Penicillin G procaine sterile* Penicillin G benzathine sterile*
    Beta-lactam Intermediates 6-amino-penicillanic acid (6-APA) 7-amino-deacetoxycephalosporanic acid (7-ADCA)
    Semi-Synthetic Penicillins Amoxicillin trihydrate Ampicillin trihydr...
  • FDF Product Portfolio

    Product FDF Product Portfolio

    Finished Dosage Forms
    Beta-lactam antibiotics
    Amoxicillin Amoxicillin + Clavulanic acid
    Statins
    Atorvastatin Rosuvastatin
    Anti-fungals
    Caspofungin

    Sterile injectables
    Semi-Synthetic Penicillins (SSP)
    Amoxicillin & Cloxacillin Ampicillin Sodium Amoxicill...
  • 6-amino-penicillanic acid (6-APA)

    Product 6-amino-penicillanic acid (6-APA)

    6-amino-penicillanic acid (6-APA)
  • Amoxicillin

    Product Amoxicillin

    Centrient Pharmaceuticals provides wide range of drug products which includes amoxicillin. Dosage form: capsules; film-coated tablets; tablets; oral suspension; sachets. Contact us for more information.
  • 7-Aminodeacetoxy-cephalosporanic acid (7-ADCA)

    Product 7-Aminodeacetoxy-cephalosporanic acid (7-ADCA)

    7-Aminodeacetoxy-cephalosporanic acid (7-ADCA)
  • Amoxicillin + Clavulanic acid

    Product Amoxicillin + Clavulanic acid

    Centrient Pharmaceuticals provides wide range of drug products which includes amoxicillin + clavulanic acid. Dosage form: film-coated tablets; oral suspension; sachets; injectables. Contact us for more information.
  • Amoxicillin

    Product Amoxicillin

    Amoxicillin
  • Atorvastatin

    Product Atorvastatin

    Centrient Pharmaceuticals provides wide range of drug products which includes atorvastatin. Dosage form: film-coated tablets. Contact us for more information.
  • Amoxicillin + Clavulanic acid

    Product Amoxicillin + Clavulanic acid

    Amoxicillin + Clavulanic acid
  • Rosuvastatin

    Product Rosuvastatin

    Centrient Pharmaceuticals provides wide range of drug products which includes rosuvastatin. Dosage form: film-coated tablets. Contact us for more information.
  • 6-amino-penicillanic acid (6-APA)

    Product 6-amino-penicillanic acid (6-APA)

    Centrient Pharmaceuticals provides wide range of intermediates which includes 6-amino-penicillanic acid (6-apa). Characteristics: a crystalline powder manufactured by an enzymatic process starting from penicillin g potassium. Application: the product is used as an intermediate for the manufacture of s...
  • Amoxicillin trihydrate compacted

    Product Amoxicillin trihydrate compacted

    Amoxicillin trihydrate compacted
show all 95 products

Centrient Pharmaceuticals Resources (2)

  • Centrient Pharmaceuticals announces completion of acquisition of Astral SteriTech

    News Centrient Pharmaceuticals announces completion of acquisition of Astral SteriTech

    Centrient Pharmaceuticals (“Centrient”), the business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals, today announced the completion of the acquisition of Astral SteriTech Private Limited (“Astral SteriTech”).

    With the addition of Astral SteriTech’s Semi-Synthetic Cephalosporin and Semi-Synthetic Penicillin sterile injectable finished dosage forms to Centrient’s product portfolio, the company can now further meet the needs of customers and reach more patients with its critical life-saving medicine.

    21 Sep 2022
  • Overview Available MAs

    Technical Data Overview Available MAs

    Available Marketing Authorizations